Thyme Care, a startup focused on helping patients navigate cancer care, is undergoing a leadership transition. Founder Robin Shah will step down as CEO on September 1st, with Dr. Brad Diephuis, the company's co-president and COO, taking over the role. This change occurs as the company experiences significant growth, with revenue surpassing $125 million last year and profitability. Shah will move to an executive chairman role, focusing on expansion into new areas like drug affordability and clinical trial access, leveraging AI and automation. AI
IMPACT Expansion into drug affordability and clinical trial access leveraging AI and automation may improve patient outcomes.
RANK_REASON Leadership change at a company that recently achieved unicorn status and is experiencing significant revenue growth. [lever_c_demoted from significant: ic=1 ai=0.4]
- Aetna
- Andreessen Horowitz
- Center for Medicare and Medicaid Innovation
- CVS Health Ventures
- Dr. Bobby Green
- Dr. Brad Diephuis
- Flatiron Health
- Forbes
- Foresite Capital
- Humana
- Robin Shah
- Roche
- Thyme Care
- Town Hall Ventures
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
